.

BioPharmaceutical Business Intelligence

  • Identify first generic entrants
  • Uncover prior art in expired and abandoned patents
  • Obtain formulation and manufacturing information

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Queensland Health
Chubb
Accenture
Federal Trade Commission
Baxter
Mallinckrodt
Fuji
Colorcon
Teva
QuintilesIMS

Generated: February 18, 2018

DrugPatentWatch Database Preview

Drug Master Files for: Eastman Kodak

« Back to Dashboard


DMF No. Status Type Submission Date Holder Subject
287I12/24/1957DISTILLATION PROD INDS DIV EASTMAN KODAK COMYVARET VITAMIN A FEED SUPPLEMENT RETINENE QUINOLATE (VET MED)
294III4/9/1958DISTILLATION PROD INDS DIV EASTMAN KODAK COINDOCYANINE GREEN
799IIV5/11/1964DISTILLATION PROD INDS DIV EASTMAN KODAK COPINACYANOLE CHLORIDE
807I6/1/1964DISTILLATION PROD INDS DIV EASTMAN KODAK CO2,6 DICHLOROINDOPHENOL SODIUM SALT
1107I12/11/1967DISTILLATION PROD INDS DIV EASTMAN KODAK COETHYL PHENYLUNDECYLATE (EASTMAN 7045)
1192III6/3/1968DISTILLATION PROD INDS DIV EASTMAN KODAK CORETINOIC ACID (EASTMAN 8098)
1959III6/30/1972EASTMAN KODAK CON,N- DIMETHYL - P - TOLUIDINE
1973IIV7/27/1972EASTMAN KODAK COGLYCOLIDE
2226III1/31/1974EASTMAN KODAK CO1-CHLORO-2, 4-DINITROBENZENE
2588I11/28/1975EASTMAN KODAK COGUANIDINE HCL
This preview shows a limited number of results
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.


Drug Master File Glossary

STATUS OF DMFS

  • A = Active. This means that the DMF was found acceptable for filing, administratively, and is up-to-date.
  • I = Inactive
  • N = Not an assigned number
  • P = DMF Pending Filing Review

TYPES OF DMFs

  • Type I Manufacturing Site, Facilities, Operating Procedures, and Personnel (no longer applicable)
  • Type II Drug Substance, Drug Substance Intermediate, and Material Used in Their Preparation, or Drug Product
  • Type III Packaging Material
  • Type IV Excipient, Colorant, Flavor, Essence, or Material Used in Their Preparation
  • Type V FDA Accepted Reference Information

« Back to Dashboard

For more information try a trial or see the plans and pricing

Serving leading biopharmaceutical companies globally:

Merck
Cipla
QuintilesIMS
McKinsey
Boehringer Ingelheim
Citi
Medtronic
Julphar
Mallinckrodt
Dow

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2018 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:

botpot